P. A. . Herliawati, D. E. P. . Harnandari, R. A. . Hildayanti, A. . Wicaksana, and P. P. . Firsta, “Malignancy Risk Index 4 (RMI 4) is better than RMI 3 as a predictor Advanced Epithelial Ovarian Carcinoma was used for NACT”, JN, vol. 7, no. 1, pp. 536–542, Apr. 2023.